BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33762581)

  • 1. Targeting replication stress to tackle cancer stem cells.
    Galluzzi L
    Cell Death Dis; 2021 Mar; 12(4):315. PubMed ID: 33762581
    [No Abstract]   [Full Text] [Related]  

  • 2. Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51.
    Manic G; Musella M; Corradi F; Sistigu A; Vitale S; Soliman Abdel Rehim S; Mattiello L; Malacaria E; Galassi C; Signore M; Pallocca M; Scalera S; Goeman F; De Nicola F; Guarracino A; Pennisi R; Antonangeli F; Sperati F; Baiocchi M; Biffoni M; Fanciulli M; Maugeri-Saccà M; Franchitto A; Pichierri P; De Maria R; Vitale I
    Cell Death Differ; 2021 Jul; 28(7):2060-2082. PubMed ID: 33531658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rad51 Degradation: Role in Oncolytic Virus-Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma.
    Ning J; Wakimoto H; Peters C; Martuza RL; Rabkin SD
    J Natl Cancer Inst; 2017 Mar; 109(3):1-13. PubMed ID: 28376211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of the nuclear isoform of poly(ADP-ribose) glycohydrolase (PARG) reveals its function in DNA repair, genomic stability and tumorigenesis.
    Min W; Cortes U; Herceg Z; Tong WM; Wang ZQ
    Carcinogenesis; 2010 Dec; 31(12):2058-65. PubMed ID: 20926829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer.
    Liu Y; Burness ML; Martin-Trevino R; Guy J; Bai S; Harouaka R; Brooks MD; Shang L; Fox A; Luther TK; Davis A; Baker TL; Colacino J; Clouthier SG; Shao ZM; Wicha MS; Liu S
    Clin Cancer Res; 2017 Jan; 23(2):514-522. PubMed ID: 28034904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric cancer associated variant of DNA polymerase beta (Leu22Pro) promotes DNA replication associated double strand breaks.
    Rozacky J; Nemec AA; Sweasy JB; Kidane D
    Oncotarget; 2015 Sep; 6(27):24474-87. PubMed ID: 26090616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced dependency of KRAS-mutant colorectal cancer cells on RAD51-dependent homologous recombination repair identified from genetic interactions in Saccharomyces cerevisiae.
    Kalimutho M; Bain AL; Mukherjee B; Nag P; Nanayakkara DM; Harten SK; Harris JL; Subramanian GN; Sinha D; Shirasawa S; Srihari S; Burma S; Khanna KK
    Mol Oncol; 2017 May; 11(5):470-490. PubMed ID: 28173629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oncoprotein DEK affects the outcome of PARP1/2 inhibition during mild replication stress.
    Ganz M; Vogel C; Czada C; Jörke V; Gwosch EC; Kleiner R; Pierzynska-Mach A; Zanacchi FC; Diaspro A; Kappes F; Bürkle A; Ferrando-May E
    PLoS One; 2019; 14(8):e0213130. PubMed ID: 31408463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stalled replication forks within heterochromatin require ATRX for protection.
    Huh MS; Ivanochko D; Hashem LE; Curtin M; Delorme M; Goodall E; Yan K; Picketts DJ
    Cell Death Dis; 2016 May; 7(5):e2220. PubMed ID: 27171262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A short G1 phase imposes constitutive replication stress and fork remodelling in mouse embryonic stem cells.
    Ahuja AK; Jodkowska K; Teloni F; Bizard AH; Zellweger R; Herrador R; Ortega S; Hickson ID; Altmeyer M; Mendez J; Lopes M
    Nat Commun; 2016 Feb; 7():10660. PubMed ID: 26876348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma cells replicate through chemotherapy by reducing levels of key homologous recombination protein RAD51 and increasing expression of translesion synthesis DNA polymerase ζ.
    Song L; McNeil EM; Ritchie AM; Astell KR; Gourley C; Melton DW
    BMC Cancer; 2017 Dec; 17(1):864. PubMed ID: 29254481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Short BRCA2-Derived Cell-Penetrating Peptide Targets RAD51 Function and Confers Hypersensitivity toward PARP Inhibition.
    Trenner A; Godau J; Sartori AA
    Mol Cancer Ther; 2018 Jul; 17(7):1392-1404. PubMed ID: 29654063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma.
    Colicchia V; Petroni M; Guarguaglini G; Sardina F; Sahún-Roncero M; Carbonari M; Ricci B; Heil C; Capalbo C; Belardinilli F; Coppa A; Peruzzi G; Screpanti I; Lavia P; Gulino A; Giannini G
    Oncogene; 2017 Aug; 36(33):4682-4691. PubMed ID: 28394338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RADX Modulates RAD51 Activity to Control Replication Fork Protection.
    Bhat KP; Krishnamoorthy A; Dungrawala H; Garcin EB; Modesti M; Cortez D
    Cell Rep; 2018 Jul; 24(3):538-545. PubMed ID: 30021152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of SIM2s inhibits RAD51 binding and leads to unresolved replication stress.
    Pearson SJ; Elswood J; Barhoumi R; Ming-Whitfield B; Rijnkels M; Porter WW
    Breast Cancer Res; 2019 Nov; 21(1):125. PubMed ID: 31775907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting NPM1 in irradiated cells inhibits NPM1 binding to RAD51, RAD51 foci formation and radiosensitizes NSCLC.
    Traver G; Sekhar KR; Crooks PA; Keeney DS; Freeman ML
    Cancer Lett; 2021 Mar; 500():220-227. PubMed ID: 33358698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiosensitization with an inhibitor of poly(ADP-ribose) glycohydrolase: A comparison with the PARP1/2/3 inhibitor olaparib.
    Gravells P; Neale J; Grant E; Nathubhai A; Smith KM; James DI; Bryant HE
    DNA Repair (Amst); 2018 Jan; 61():25-36. PubMed ID: 29179156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAD52 Facilitates Mitotic DNA Synthesis Following Replication Stress.
    Bhowmick R; Minocherhomji S; Hickson ID
    Mol Cell; 2016 Dec; 64(6):1117-1126. PubMed ID: 27984745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncoupling of RAD51 focus formation and cell survival after replication fork stalling in RAD51D null CHO cells.
    Urbin SS; Elvers I; Hinz JM; Helleday T; Thompson LH
    Environ Mol Mutagen; 2012 Mar; 53(2):114-24. PubMed ID: 22302683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the DNA damage response in oncology: past, present and future perspectives.
    Basu B; Yap TA; Molife LR; de Bono JS
    Curr Opin Oncol; 2012 May; 24(3):316-24. PubMed ID: 22476188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.